Erik Olai Pettersen

Erik Olai Pettersen is affiliated with the Department of Physics at the University of Oslo, focusing on radiobiology, cancer research, and hypoxia-driven mechanisms in tumors. He has supervised 38 master’s and 10 doctoral students. His work bridges laboratory research with clinical implications, particularly in radiation therapy and tumor microenvironment dynamics.

Education & Employment: Civil Engineer (Biophysics) from NTH (Trondheim, 1972), Dr. philos (Radiobiology, University of Oslo, 1979). Long-term academic staff member with international research leadership roles in networks like METOXIA and OXNORM.

Research Interests: Radiosensitivity modulation, hypoxia’s role in cancer therapy resistance, oxygen biology, and development of biosensors for in vitro studies. Key contributions include understanding hypoxia-induced metabolic shifts and optimizing radiation protocols using low-dose-rate strategies.

Articles Overview: Recent work emphasizes photodynamic therapy monitoring, alginate-based cell culture systems, and hypoxia’s impact on mitochondrial function. His studies highlight translational applications in drug development and tumor metastasis prevention.

Grants & Networks: Coordinated EU-funded projects (METOXIA, EUROXY) totaling over 20 partners. Focus areas include normoxia research, oxygen-sensing technologies, and drug candidate screening for hypoxic tumors.

Labs & Teams: Collaborates with interdisciplinary teams in physics, oncology, and biomedical engineering, leveraging advanced biosensing and microfluidic platforms.